
Spruce Biosciences Inc is a biotechnology business based in the US. Spruce Biosciences Inc shares (SPRB) are listed on the NASDAQ and all prices are listed in US Dollars. Spruce Biosciences Inc employs 16 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Spruce Biosciences Inc
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SPRB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Spruce Biosciences Inc stock price (NASDAQ: SPRB)
Use our graph to track the performance of SPRB stocks over time.Spruce Biosciences Inc shares at a glance
Latest market close | $1.66 |
---|---|
52-week range | $1.25 - $11.51 |
50-day moving average | $1.66 |
200-day moving average | $3.11 |
Wall St. target price | $9.17 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.89 |
Buy Spruce Biosciences Inc shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Spruce Biosciences Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Spruce Biosciences Inc price performance over time
Historical closes compared with the close of $1.66 from 2022-06-24
1 week (2022-06-16) | 13.70% |
---|---|
1 month (2022-05-25) | 25.76% |
3 months (2022-03-22) | N/A |
6 months (2021-12-23) | -55.38% |
1 year (2021-06-25) | -84.91% |
---|---|
2 years (2020-06-22) | N/A |
3 years (2019-06-22) | N/A |
5 years (2017-06-22) | N/A |
Spruce Biosciences Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -20.44% |
Return on equity TTM | -36.66% |
Profit margin | 0% |
Book value | $4.27 |
Market capitalisation | $42.8 million |
TTM: trailing 12 months
Spruce Biosciences Inc share dividends
We're not expecting Spruce Biosciences Inc to pay a dividend over the next 12 months.
Spruce Biosciences Inc overview
Spruce Biosciences, Inc. , a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.
Spruce Biosciences Inc in the news
Spruce Biosciences to Participate in June Investor Conferences
Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
Frequently asked questions
What percentage of Spruce Biosciences Inc is owned by insiders or institutions?Currently 0.025% of Spruce Biosciences Inc shares are held by insiders and 89.104% by institutions. How many people work for Spruce Biosciences Inc?
Latest data suggests 16 work at Spruce Biosciences Inc. When does the fiscal year end for Spruce Biosciences Inc?
Spruce Biosciences Inc's fiscal year ends in December. Where is Spruce Biosciences Inc based?
Spruce Biosciences Inc's address is: 2001 Junipero Serra Boulevard, Daly City, CA, United States, 94014 What is Spruce Biosciences Inc's ISIN number?
Spruce Biosciences Inc's international securities identification number is: US85209E1091
More guides on Finder
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
-
How to buy NYIAX (NYX) stock when it goes public
Everything we know about the NYIAX IPO, plus information on how to buy in.
-
How to buy Adamas One Corp (JEWL) stock when it goes public
Everything we know about the Adamas One Corp IPO, plus information on how to buy in.
-
How to buy Glucose Health (GLUC) stock when it goes public
Everything we know about the Glucose Health IPO, plus information on how to buy in.
-
How to buy Boustead Wavefront (BOUW) stock when it goes public
Everything we know about the Boustead Wavefront IPO, plus information on how to buy in.
-
How to buy ParaZero Technologies (PRZO) stock when it goes public
Everything we know about the ParaZero Technologies IPO, plus information on how to buy in.
Ask an Expert